IRIS
D'ANGELO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.044
EU - Europa 3.190
AS - Asia 2.205
AF - Africa 8
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.011
CN - Cina 2.166
IE - Irlanda 1.065
UA - Ucraina 635
FI - Finlandia 484
DE - Germania 395
SE - Svezia 220
IT - Italia 154
GB - Regno Unito 147
FR - Francia 40
CA - Canada 32
IN - India 25
BE - Belgio 20
NL - Olanda 13
MU - Mauritius 8
RU - Federazione Russa 8
TR - Turchia 5
AT - Austria 2
JP - Giappone 2
MK - Macedonia 2
PL - Polonia 2
SG - Singapore 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CR - Costa Rica 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
KH - Cambogia 1
KR - Corea 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PE - Perù 1
Totale 9.452
Salva come PNG Salva come JPEG
Città #
Dublin 1.065
Chandler 894
Jacksonville 848
Nanjing 653
Nanchang 287
Ashburn 256
Shenyang 198
Princeton 194
Lawrence 190
Medford 186
Hebei 180
Wilmington 172
Changsha 162
Jiaxing 162
Beijing 155
Helsinki 147
Hangzhou 108
Boardman 102
Tianjin 97
Ann Arbor 90
Woodbridge 53
Cambridge 51
Seattle 33
Milan 31
Shanghai 31
Toronto 30
Pavia 28
Fairfield 26
New York 26
Norwalk 24
Des Moines 22
Jinan 21
Pune 21
Kunming 19
Brussels 18
Verona 17
Los Angeles 16
Taizhou 12
Ningbo 11
Orange 11
Washington 11
Guangzhou 9
West Jordan 8
Berlin 7
Eindhoven 7
Fuzhou 7
Dearborn 6
Houston 5
Lanzhou 5
Redwood City 5
San Francisco 5
Zhengzhou 5
Auburn Hills 4
Collegno 4
Genoa 4
Isernia 4
Paris 4
Tappahannock 4
Catania 3
Haikou 3
Hanover 3
Hefei 3
Parma 3
Bareggio 2
Bruino 2
Changchun 2
Falkenstein 2
Falls Church 2
Frankfurt am Main 2
Grandate 2
Gunzenhausen 2
Jinhua 2
Kochi 2
London 2
Magnago 2
Moscow 2
Phoenix 2
Portland 2
Potomac 2
Salerno 2
Singapore 2
Almere Stad 1
Amsterdam 1
Atella 1
Atlanta 1
Bitola 1
Borås 1
Buia 1
Böblingen 1
Carpenedolo 1
Charlotte 1
Cozzo 1
Dalby 1
Duncan 1
Eau Claire 1
Edmond 1
Enna 1
Ergolding 1
Franklin Square 1
Gdansk 1
Totale 6.821
Salva come PNG Salva come JPEG
Nome #
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 145
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 91
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 88
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 81
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 78
RAGE : a central player in nondiabetic vascular disease 77
The Apolipoprotein(a) Component of Lipoprotein(a) Mediates Binding to Laminin: Contribution to Selective Retention of Lipoprotein(a) in Atherosclerotic Lesions 77
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 75
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 74
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 74
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 73
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 72
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 71
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 70
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 70
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 70
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 69
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 69
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 68
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 67
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 66
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 66
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 65
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 64
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 61
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 61
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 61
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 61
Effects of berberine on lipid profile in subjects with low cardiovascular risk 61
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 61
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 61
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 61
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 61
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 60
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 59
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 59
Olmesartan/amlodipine combination vs olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients 59
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 58
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 58
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 58
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 58
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 58
Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients 58
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 58
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 58
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 57
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients 57
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 57
Efficacia e sicurezza di pioglitazone o rosiglitazone in combinazione con metformina in pazienti con diabete di tipo 2 e sindrome metabolica 57
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 57
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 57
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 56
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 56
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 56
Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin 56
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 55
Matrix metalloproteinase-2 and – 9 levels in obese patients 55
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 55
Candesartan effect on inflammation in hypertension 55
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 55
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 55
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 55
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 54
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 54
La terapia con rosiglitazone migliora i parametri di insulino-resisitenza nei pazienti diabetici in sovrappeso ed obesi intolleranti alla metformina 54
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 54
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 54
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 54
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 54
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 53
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients before and after antihypertensive therapy 53
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 53
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin 53
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 53
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients. 53
Effetti di sitagliptin o metformina associati a pioglitazone in pazienti diabetici scarsamente controllati 53
Effects of sibutramine plus L-carnitine compared to sibutramine or placebo on inflammatory parameters 53
Effetti di una combinazione di un estratto di berberis aristata/silybum marianum sul profilo lipidico e la secrezione insulinica in pazienti dislipidemici 53
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 53
Matrix metalloproteinase-2,-9 and tissue inhibitor metalloproteinase-1,-2 in healthy and type 2 diabetic subjects 53
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 52
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients 52
Efficacia e sicurezza del pioglitazone o rosiglitazone in combinazione con metformina su pazienti diabetici dislipidemici 52
Low plasma apelin levels predict arrhythmia recurrence in patients with persistent atrial fibrillation 52
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 52
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 51
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 51
Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients 51
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 51
La doxazosina migliora i parametri pressori e l'assetto metabolico nei soggetti intolleranti al glucosio in terapia con acarbose 51
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial 50
Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes 50
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 50
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type2 diabetic patients not well controlled by metformin 50
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance 50
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 50
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 50
The apolipoprotein(a) size polymorphism is assocated with Alzheimer's disease and vascular dementia 49
Effect of acarbose on inflammatory parameters at baseline and after an oral fat load: a double-blind, placebo controlled trial 49
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone: a double-blind, randomised clinical trial 49
Totale 5.994
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 0 58 9
2019/20202.604 732 1.118 8 118 2 140 36 128 11 216 90 5
2020/20211.190 140 110 37 117 2 160 9 187 43 186 157 42
2021/2022740 12 4 30 5 6 10 5 46 44 15 119 444
2022/20232.856 286 200 20 189 282 283 2 163 1.253 35 90 53
2023/2024844 110 179 28 58 88 226 5 100 9 39 2 0
Totale 9.675